![]() |
![]() |
![]() |
![]() |
![]() |
December/January 2003 Editors: Betty Spinner, Liz Sklar, Barbara Z. and Steven Goodman.
Featured Stories:
Kadima's New Clinical Director
Kadima's New Clinical Director I spent some time talking with Kadima's new Clinical Director, Nancy Stein. Here are some highlights of our conversation. Kadima Voice: First
of all, how did you become aware of Kadima? KV: Are you planning on making changes at
Kadima? KV: How were you welcomed at
Kadima? KV: Have you read the
Kadima Voice? KV:
What positions have you held in the mental health field? KV: What
do you look forward to at Kadima?
Kadima Thanksgiving and Hanukkah Dinner Have you ever had potato latkes at a Thanksgiving dinner? I never had until Monday night (November 25) at Kadima's combination Thanksgiving and Hanukkah dinner. They were very tasty and went well with turkey. Normally, Kadima celebrates these two holidays separately. Because they fell so close together this year, it was decided to combine them. This event was held at the Berkley First United Methodist Church. The church is only about a mile and a half from Kadima's offices, so it was very convenient. Of course, there was plenty of food. Geta Richman, our retired clinical director, brought a turkey to share with us. Many Kadima clients contributed to the dinner. There were the standard items: Turkey, stuffing, vegetables, various side dishes, soft drinks, etc, and those potato latkes. It was finished up with dessert, including the requisite pumpkin pie and cookies and cake. During our dinner, we were entertained by Michael Krieger on the piano. He sang many popular songs from the 1960's and the 1970's. Some people requested songs that he played as well. A few people had him accompany them on piano while they sang. They were Michael Basel, Joel Kraus, and our very own Kadima Voice editor, Betty Spinner. She sang "Take Me Out To The Ballgame." Betty is a very big Tigers fan. No one else was thinking about baseball, but she was. Besides potato latkes to remind us of Hanukkah, there were also gifts. We each received a grab bag full of useful and fun items. There were also hats and gloves available to keep us warm this winter. These gifts and a donation for the dinner were given by the Zager-Stone / Tucker-Grant Lodge of the B'nai B'rith. We would like to thank the Kadima staff and other volunteers who helped out at this event. Thanks to the Berkley First United Methodist Church for providing their facilities. Also, special appreciation to the B'nai B'rith. It was a very nice evening seeing old friends and celebrating the holidays.
Patch Raises New Hope For Beating Depression It was the first type of antidepressant, and for many people the
monamine oxidase inhibitor remains the best hope for relief from major
depression. The trouble is, the side effects can be so serious that MAO
inhibitors are rarely prescribed. When taken with certain foods, for
example, they may bring on sudden and severe hypertension. The problems, however, may soon be resolved. A study reported in the November issue of the American Journal of
Psychiatry suggests that by administering the MAO inhibitor selegiline
in patch form, patients can receive the antidepressant benefits of the
drug without the usual side effects. In research conducted at six sites, 42 percent of the subjects
treated with the patch recovered from major depression within six weeks,
and many showed great improvement much sooner. In the study, neither
subjects nor researchers knew who had received the dummy medication. One subject, requesting anonymity, told how his mood changed after a
few weeks on the patch, saying, "It was like a switch had gone on.
Before I had the patch, I couldn't function. Suddenly, I had a dramatic
change in outlook. I could look forward to things." Monamine oxidase is an enzyme found in the brain and digestive
system. By inhibiting MAO in the brain, the antidepressant is believed
to give patients a better supply of neurotransmitters to fight the
symptoms of depression. Taken orally, however, the medication also
blocks MAO in the digestive system, and that interferes with the
detoxification of tyramine, a harmful byproduct of many aged foods. Patients receiving MAO inhibitors are instructed to follow a tyramine-restrictive
diet, which means no aged cheeses, no red wine, no soy sauce, no
fermented foods and little or no alcohol. Eating tyramine-rich food
while taking an MAO inhibitor can cause sudden and severe hypertension. Delivering selegiline through the skin, however, changes the way the
medication is absorbed. Rather than first being filtered through the
intestines and liver, in patch form, the drug is targeted to the central
nervous system. "With this study we've demonstrated a way of getting an MAO
inhibitor to the brain without interfering with the MAO in the digestive
system," said the study's lead author, Dr. Alexander Bodkin of the
clinical psychopharmacology research program of McLean Hospital in
Belmont, Mass. The study was supported by the developers of the
selegiline patch, Somerset Pharmaceuticals of Tampa, Fla. While subjects in this study were instructed to follow a tyramine-restricted
diet, in subsequent studies they were not. Dr. Beverly McCabe, a professor of dietetics and nutrition at the
University of Arkansas at Little Rock and a co-author of the
"Handbook of Food and Drug Interaction," to be published in
January, believes this form of drug delivery offers great promise.
"I would think the risk of a tyramine reaction would be very low
with transdermal selegiline," McCabe said. "The drug would be
absorbed into the bloodstream more evenly, which would also be
beneficial." Dr. Frederic Quitkin, director of the depression evaluation service
at the New York State Psychiatric Institute in Manhattan, said,
"MAO inhibitors are really great drugs: complicated to use but
extremely effective." As for the selegiline patch, he said, the
research is encouraging. But, he cautioned, "It will require
further study to see how effective it is." Another notable finding in the study of 177 patients was the 94
percent compliance rate for those on the selegiline patch. That is
significant, said Bodkin, because compliance rates with oral
antidepressants are typically much lower. One side effect, in 36 percent of subjects, was a reaction, like
redness or irritation, at the site of the patch. For most patients,
Bodkin said, the irritation is minor compared with the side effects of
most antidepressants.
Bubbi Knows Best Q: Where I live, we have a problem with our toilet overflowing. Do you
have any suggestions? Q: Why is everybody in a hurry when they drive a car? Q: What causes anxiety in most people? Q: What makes people late for activities or functions?
15999 W. Twelve Mile Road, Second Floor
248.559.8235
©2003 Kadima |